Atlas Trials

Study of Daratumumab in Patients With Mild to Moderate Alzheimer's Disease

Clinical trial NCT04070378 · COMPLETED

Trial details

NCT number
NCT04070378
Sponsor
Marc L Gordon, MD
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2019-11-06
Primary completion
2023-06-08
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.